Emerging Strategies in the Treatment of Genitourinary Cancers (Prostate Cancer, Renal Cell Carcinoma and Urothelial Carcinoma) – Enduring Webcast

Description

Program Description

---

The treatment of genitourinary malignancies has dramatically evolved over recent years. Renal cell carcinoma, urothelial carcinoma, and prostate cancer are the most encountered genitourinary malignancies and represent a heterogeneous population of cancers, in both histology and approach to treatment. However, all three cancers have undergone paradigm shifts in their respective therapeutic landscapes due to a greater understanding of their underlying molecular mechanisms and oncogenic drivers

Intended Audience

---

Hematologists/oncologists, physician assistants, nurse practitioners, and nurses

Commercial Supporter

---

This activity is supported by an educational grant from Exelixis, Inc and Bristol Myers Squibb.